By Viviane Trojan
Life Sciences’ Brazil Global Guide 2024 is now available
We are pleased to announce our collaboration on the Chambers and Partners Life Sciences 2024 Global Practice Guide!
Our partners Priscila Kashiwabara and Viviane Trojan, along with attorneys at law Gustavo Vicenti and Giovanna Verginelli Mezher, authored the Life Sciences 2024 guide for Brazil, that outlines the regulatory framework for pharmaceuticals and medical devices, detailing the legislation, regulatory bodies and procedures for securing approvals and handling appeals. It covers categorisation, clinical trials, marketing authorizations and ongoing obligations.
The guide also emphasizes ANVISA’s role in regulation, the stringent requirements for biologics and the procedures for compassionate use and post-marketing surveillance. Additionally, it addresses manufacturing authorizations, distribution regulations and measures against counterfeit products.
For more details, click here.
Last by Viviane Trojan
December 27, 2024
Bioinputs Law: A new regulatory framework for sustainable agriculture in Brazil
On December 24, 2024, Law No. 15,070 of December 23, 2024 (“Bioinputs Law”), which regulates the production, use, and commercialization of bioinputs … Bioinputs Law: A new regulatory framework for sustainable agriculture in Brazil
December 23, 2024
Brazilian court prohibits royalty collection for public domain technology
On the last working day of the Judiciary before the court recess (a period during which legal deadlines are suspended and no … Brazilian court prohibits royalty collection for public domain technology
October 14, 2024
Kasznar Leonardos will be participating in the IAM and WTR Live: Latin America IP Summit
Our partners Tatiana Silveira, Viviane Trojan, Patrícia Lopes, and business developer Pedro Sanzovo will be attending the IAM and WTR Live: Latin … Kasznar Leonardos will be participating in the IAM and WTR Live: Latin America IP Summit